This document is a publication from the European Patent Office (EPO) detailing patent application EP4153611A1, titled 'Therapeutic potential of peptides from the "netrin-like" domain of the Frzb protein'. The publication, dated March 11, 2026, lists the applicants as Université de Lorraine, Centre National de la Recherche Scientifique, and Centre Hospitalier Régional Universitaire de Nancy, along with the inventors. It includes International Patent Classification (IPC) codes related to peptides and their therapeutic use.

As this is a patent publication, it does not impose direct compliance obligations on regulated entities. However, it is relevant for pharmaceutical and biotechnology companies involved in research and development of peptide-based therapeutics. Companies operating in the EU should be aware of this patent filing for potential intellectual property considerations and competitive landscape analysis. No specific compliance actions or deadlines are associated with this notice.